IL-1β and TGFβ2 synergistically induce endothelial to mesenchymal transition in an NFκB-dependent manner

Immunobiology

Volumn 218, Issue 4, 2013, Pages 443-454

  Maleszewska, Monika ^a   Moonen, Jan Renier A J ^a   Huijkman, Nicolette ^a   van de Sluis, Bart ^a   Krenning, Guido ^a   Harmsen, Martin C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

EndMT; Fibrosis; IL 1 ; Inflammation; NF B; TGF 2

Indexed keywords

CALPONIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; ISOPROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSGELIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIAL MESENCHYMAL TRANSITION; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; MALE; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL NUCLEUS; CELLULAR MICROENVIRONMENT; ENDOTHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; MALE; MICE; NF-KAPPA B; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

EID: 84875232512     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.05.026     Document Type: Article

References (50)

1. Arciniegas E., Carrillo L.M., De Sanctis J.B., Candelle D. Possible role of NFkappaB in the embryonic vascular remodeling and the endothelial mesenchymal transition process. Cell Adhes. Migr. 2008, 2:17-29.
2. Arciniegas E., Sutton A.B., Allen T.D., Schor A.M. Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. J. Cell Sci. 1992, 103(Pt 2):521-529.
3. Armstrong E.J., Bischoff J. Heart valve development: endothelial cell signaling and differentiation. Circ. Res. 2004, 95:459-470.
4. Azhar M., Runyan R.B., Gard C., Sanford L.P., Miller M.L., Andringa A., et al. Ligand-specific function of transforming growth factor beta in epithelial-mesenchymal transition in heart development. Dev. Dyn. 2009, 238:431-442.
5. Barbieri S.S., Ruggiero L., Tremoli E., Weksler B.B. Suppressing PTEN activity by tobacco smoke plus interleukin-1beta modulates dissociation of VE-cadherin/beta-catenin complexes in endothelium. Arterioscler. Thromb. Vasc. Biol. 2008, 28:732-738.
6. Barbieri S.S., Weksler B.B. Tobacco smoke cooperates with interleukin-1beta to alter beta-catenin trafficking in vascular endothelium resulting in increased permeability and induction of cyclooxygenase-2 expression in vitro and in vivo. FASEB J. 2007, 21:1831-1843.
7. Basile D.P., Friedrich J.L., Spahic J., Knipe N., Mang H., Leonard E.C., et al. Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am. J. Physiol. Renal Physiol. 2011, 300:F721-F733.
8. Boyer A.S., Ayerinskas I.I., Vincent E.B., McKinney L.A., Weeks D.L., Runyan R.B. TGFbeta2 and TGFbeta3 have separate and sequential activities during epithelial-mesenchymal cell transformation in the embryonic heart. Dev. Biol. 1999, 208:530-545.
9. Bujak M., Dobaczewski M., Chatila K., Mendoza L.H., Li N., Reddy A., et al. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am. J. Pathol. 2008, 173:57-67.
10. Bujak M., Frangogiannis N.G. The role of IL-1 in the pathogenesis of heart disease. Arch. Immunol. Ther. Exp. (Warsz) 2009, 57:165-176.
11. Burmester J.K., Qian S.W., Roberts A.B., Huang A., Amatayakul-Chantler S., Suardet L., et al. Characterization of distinct functional domains of transforming growth factor beta. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:8628-8632.
12. Camenisch T.D., Molin D.G., Person A., Runyan R.B., Gittenberger-de Groot A.C., McDonald J.A., et al. Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis. Dev. Biol. 2002, 248:170-181.
13. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2000, 2:76-83.
14. Chaudhuri V., Zhou L., Karasek M. Inflammatory cytokines induce the transformation of human dermal microvascular endothelial cells into myofibroblasts: a potential role in skin fibrogenesis. J. Cutan. Pathol. 2007, 34:146-153.
15. Chimal-Monroy J., Diaz de Leon L. Differential effects of transforming growth factors beta 1, beta 2, beta 3 and beta 5 on chondrogenesis in mouse limb bud mesenchymal cells. Int. J. Dev. Biol. 1997, 41:91-102.
16. Fleenor B.S., Marshall K.D., Rippe C., Seals D.R. Replicative aging induces endothelial to mesenchymal transition in human aortic endothelial cells: potential role of inflammation. J. Vasc. Res. 2011, 49:59-64.
17. Frid M.G., Kale V.A., Stenmark K.R. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ. Res. 2002, 90:1189-1196.
18. Goumans M.J., Valdimarsdottir G., Itoh S., Lebrin F., Larsson J., Mummery C., et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol. Cell 2003, 12:817-828.
19. Hashimoto N., Phan S.H., Imaizumi K., Matsuo M., Nakashima H., Kawabe T., et al. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 2010, 43:161-172.
20. Hinck A.P., Archer S.J., Qian S.W., Roberts A.B., Sporn M.B., Weatherbee J.A., et al. Transforming growth factor beta 1: three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor beta 2. Biochemistry 1996, 35:8517-8534.
21. Ishisaki A., Hayashi H., Li A.J., Imamura T. Human umbilical vein endothelium-derived cells retain potential to differentiate into smooth muscle-like cells. J. Biol. Chem. 2003, 278:1303-1309.
22. Jennings J.C., Mohan S., Linkhart T.A., Widstrom R., Baylink D.J. Comparison of the biological actions of TGF beta-1 and TGF beta-2: differential activity in endothelial cells. J. Cell. Physiol. 1988, 137:167-172.
23. Kanaji N., Sato T., Nelson A., Wang X., Li Y., Kim M., et al. Inflammatory cytokines regulate endothelial cell survival and tissue repair functions via NF-kappaB signaling. J. Inflamm. Res. 2011, 4:127-138.
24. Kawaguchi M., Takahashi M., Hata T., Kashima Y., Usui F., Morimoto H., et al. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 2011, 123:594-604.
25. Kokudo T., Suzuki Y., Yoshimatsu Y., Yamazaki T., Watabe T., Miyazono K. Snail is required for TGFbeta-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells. J. Cell Sci. 2008, 121:3317-3324.
26. Krenning G., Moonen J.R., van Luyn M.J., Harmsen M.C. Vascular smooth muscle cells for use in vascular tissue engineering obtained by endothelial-to-mesenchymal transdifferentiation (EnMT) on collagen matrices. Biomaterials 2008, 29:3703-3711.
27. Labelle M., Begum S., Hynes R.O. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 2011, 20:576-590.
28. Liebner S., Cattelino A., Gallini R., Rudini N., Iurlaro M., Piccolo S., et al. Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J. Cell Biol. 2004, 166:359-367.
29. Markwald R.R., Fitzharris T.P., Manasek F.J. Structural development of endocardial cushions. Am. J. Anat. 1977, 148:85-119.
30. Medici D., Potenta S., Kalluri R. Transforming growth factor-beta2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling. Biochem. J. 2011, 437:515-520.
31. Mercado-Pimentel M.E., Runyan R.B. Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart. Cells Tissues Organs 2007, 185:146-156.
32. Micalizzi D.S., Farabaugh S.M., Ford H.L. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J. Mammary Gland Biol. Neoplasia 2010, 15:117-134.
33. Moonen J.R., Krenning G., Brinker M.G., Koerts J.A., van Luyn M.J., Harmsen M.C. Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny. Cardiovasc. Res. 2010, 86:506-515.
34. Ottmann O.G., Pelus L.M. Differential proliferative effects of transforming growth factor-beta on human hematopoietic progenitor cells. J. Immunol. 1988, 140:2661-2665.
35. Paranya G., Vineberg S., Dvorin E., Kaushal S., Roth S.J., Rabkin E., et al. Aortic valve endothelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiation in vitro. Am. J. Pathol. 2001, 159:1335-1343.
36. Potenta S., Zeisberg E., Kalluri R. The role of endothelial-to-mesenchymal transition in cancer progression. Br. J. Cancer 2008, 99:1375-1379.
37. Qian S.W., Burmester J.K., Sun P.D., Huang A., Ohlsen D.J., Suardet L., et al. Characterization of mutated transforming growth factor-beta s which possess unique biological properties. Biochemistry 1994, 33:12298-12304.
38. Qian S.W., Burmester J.K., Tsang M.L., Weatherbee J.A., Hinck A.P., Ohlsen D.J., et al. Binding affinity of transforming growth factor-beta for its type II receptor is determined by the C-terminal region of the molecule. J. Biol. Chem. 1996, 271:30656-30662.
39. Rieder F., Kessler S.P., West G.A., Bhilocha S., de la Motte C., Sadler T.M., et al. Inflammation-induced endothelial-to-mesenchymal transition a novel mechanism of intestinal fibrosis. Am. J. Pathol. 2011, 179:2660-2673.
40. Romano L.A., Runyan R.B. Slug is an essential target of TGFbeta2 signaling in the developing chicken heart. Dev. Biol. 2000, 223:91-102.
41. Romano L.A., Runyan R.B. Slug is a mediator of epithelial-mesenchymal cell transformation in the developing chicken heart. Dev. Biol. 1999, 212:243-254.
42. Schoemaker M.H., Ros J.E., Homan M., Trautwein C., Liston P., Poelstra K., et al. Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-kappaB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis. J. Hepatol. 2002, 36:742-750.
43. Stables M.J., Shah S., Camon E.B., Lovering R.C., Newson J., Bystrom J., et al. Transcriptomic analyses of murine resolution-phase macrophages. Blood 2011, 118:e192-e208.
44. Tavares A.L., Mercado-Pimentel M.E., Runyan R.B., Kitten G.T. TGF beta-mediated RhoA expression is necessary for epithelial-mesenchymal transition in the embryonic chick heart. Dev. Dyn. 2006, 235:1589-1598.
45. Wang B., Koh P., Winbanks C., Coughlan M.T., McClelland A., Watson A., et al. miR-200a prevents renal fibrogenesis through repression of TGF-beta2 expression. Diabetes 2011, 60:280-287.
46. Webb D.J., Atkins T.L., Crookston K.P., Burmester J.K., Qian S.W., Gonias S.L. Transforming growth factor beta isoform 2-specific high affinity binding to native alpha 2-macroglobulin, Chimeras identify a sequence that determines affinity for native but not activated alpha 2-macroglobulin. J. Biol. Chem. 1994, 269:30402-30406.
47. Zeisberg E.M., Potenta S., Xie L., Zeisberg M., Kalluri R. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 2007, 67:10123-10128.
48. Zeisberg E.M., Potenta S.E., Sugimoto H., Zeisberg M., Kalluri R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J. Am. Soc. Nephrol. 2008, 19:2282-2287.
49. Zeisberg E.M., Tarnavski O., Zeisberg M., Dorfman A.L., McMullen J.R., Gustafsson E., et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 2007, 13:952-961.
50. Zhao M., Fajardo G.A., Urashima T., Spin J.M., Poorfarahani S., Rajagopalan V., et al. Cardiac pressure overload hypertrophy is differentially regulated by {beta}-adrenergic receptors. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H1461-H1470.